Grant: Discovery Grants Program - Individual
McGill University
$36,000.00
Iron metabolism and hepatitis C virus
FY 2012-13
Summary
Infection with hepatitis C virus (HCV) poses a serious health care problem worldwide and is the leading cause of blood-transmitted chronic hepatitis, liver cirrhosis and hepatocellular cancer. The course of HCV infection is affected by various factors, including the body's iron status. Here we will employ a cell culture model for HCV replication (infectious ""replicon"") to study mechanisms by which HCV affects systemic and cellular iron homeostasis. We recently showed that administration of iron to HCV infected cells dramatically decreases viral replication. In earlier experiments, we also demonstrated that iron inhibits the function of the HCV RNA polymerase, a protein essential for viral replication. These findings are unexpected, considering that iron overload aggravates viral hepatitis C; thus, our data suggest that the adverse clinical effects of iron on HCV-infected patients are indirect.
We plan to extend our previous studies and utilize the replicon model system to address how HCV infection affects iron metabolism in permissive cells. Moreover, we will investigate the effects of HCV infection in the expression of hepcidin, the master hormonal regulator of systemic iron homeostasis, which controls dietary iron uptake and iron traffic in the body. This project is expected to provide new insights on the interplay between iron metabolism and HCV biology, which is crucial for understanding disease pathogenesis and for the development of new therapeutic strategies.
Program
Discovery Grants Program - Individual
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
288283-2011
Name nom
Pantopoulos, Konstantinos
Department département
Medicine
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2012
Competition year année de concours
2011
Award amount
36000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5408
Research subject group en
Biochemistry
Research subject group fr
Biochimie
Research subject en
Metabolism
Research subject fr
Métabolisme
Partie
2
Nb partie
5
Application title
Iron metabolism and hepatitis C virus
Keyword
NSERC
Application summary
Infection with hepatitis C virus (HCV) poses a serious health care problem worldwide and is the leading cause of blood-transmitted chronic hepatitis, liver cirrhosis and hepatocellular cancer. The course of HCV infection is affected by various factors, including the body's iron status. Here we will employ a cell culture model for HCV replication (infectious ""replicon"") to study mechanisms by which HCV affects systemic and cellular iron homeostasis. We recently showed that administration of iron to HCV infected cells dramatically decreases viral replication. In earlier experiments, we also demonstrated that iron inhibits the function of the HCV RNA polymerase, a protein essential for viral replication. These findings are unexpected, considering that iron overload aggravates viral hepatitis C; thus, our data suggest that the adverse clinical effects of iron on HCV-infected patients are indirect.
We plan to extend our previous studies and utilize the replicon model system to address how HCV infection affects iron metabolism in permissive cells. Moreover, we will investigate the effects of HCV infection in the expression of hepcidin, the master hormonal regulator of systemic iron homeostasis, which controls dietary iron uptake and iron traffic in the body. This project is expected to provide new insights on the interplay between iron metabolism and HCV biology, which is crucial for understanding disease pathogenesis and for the development of new therapeutic strategies.